Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Argeris N. Karabelas currently holds 10,000 shares of INOTEK PHARMACEUTICALS CORP (ITEK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Argeris N. Karabelas has been a net seller of ITEK stock. They have purchased $3.9M and sold $75.5M worth of shares.
Argeris N. Karabelas's most recent insider trade was on Oct 1, 2024, when they sold 10,000 shares at $0.00 per share.
Argeris N. Karabelas serves as Executive at INOTEK PHARMACEUTICALS CORP (ITEK). They have executed 91 insider transactions totaling $79.3M over their tenure at the company.
Argeris N. Karabelas holds the position of Executive at INOTEK PHARMACEUTICALS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Argeris N. Karabelas has shown a selling trading pattern, with $3.9M in total purchases and $75.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Argeris N. Karabelas was on Feb 23, 2015, when they purchased $3.6M worth of ITEK shares. This transaction involved 603,832 shares at $6.00 per share.
Argeris N. Karabelas currently owns 10,000 shares of INOTEK PHARMACEUTICALS CORP (ITEK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Argeris N. Karabelas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Argeris N. Karabelas has 91 Form 4 filings on record as an insider at INOTEK PHARMACEUTICALS CORP.
Set alerts for Argeris N. Karabelas and 40,000+ other insiders.